Congratulations to the members of the Department of Neurology who received accolades through the Supporting a Fair Environment (SAFE) program! SAFE aims to improve the learning environment by promoting positive behaviors and managing concerns about learner mistreatment and unprofessional behaviors. SAFE accolades include treating others with dignity and respect, creating an environment that values diversity, […]
Washington University School of Medicine in St. Louis has received a three-year, $4.5 million grant from the Carol and Gene Ludwig Family Foundation, aimed at advancing research on neuroimmunology and neurodegeneration with the ultimate goal of developing new treatments for Alzheimer’s disease. Administered by WashU Medicine’s Brain Immunology & Glia (BIG) Center, the Carol and […]
Xing “Cathy” Dai, MD, is the newest member of the Adult Neurology Residency Program leadership team at Washington University School of Medicine in St. Louis. She will join Salim Chahin, MD, MSCE, Renee Van Stavern, MD, and Gregory Wu, MD, PhD, as an associate program director, starting July 1, 2025. She began transitioning into the […]
Protein accumulations do important work in the human body, but something can go wrong and proliferate in those aggregates, resulting in neurodegeneration and diseases such as Parkinson’s and Alzheimer’s. One such assembly, amyloid beta peptide, is synonymous with dementia, but researchers were not certain how these peptide assemblies “break bad” and what really causes them […]
Washington University School of Medicine in St. Louis is one of only ten sites in the world participating in a pioneering clinical trial evaluating TSHA-102, an investigational gene therapy for the treatment of Rett syndrome, a severe neurodevelopmental disorder primarily affecting girls. The REVEAL Phase 1/2 clinical trial represents a significant advancement in the quest […]
Jacki Mallmann began her career at Washington University School of Medicine in St. Louis in 1998 as a part-time administrative assistant in the Department of Psychiatry. She spent fourteen years working at the Midwest Alcoholism Research Center, where she gained invaluable administrative research experience by working on multiple NIH-funded studies, IRB submissions, data entry, general […]
Studies have shown that Black children with serious illnesses are less likely than white children to obtain crucial genetic testing necessary to guide treatment decisions, but the reasons for this disparity have not been fully understood. A new study from Washington University School of Medicine in St. Louis focused on children with neurological conditions finds […]
In the past two years, the Food and Drug Administration has approved two novel Alzheimer’s therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease. But while the approvals of lecanemab and donanemab, both antibody therapies that clear plaque-causing amyloid proteins from the brain, were greeted with enthusiasm […]
The Jansky/Bander Family Fund, a generous commitment of $1,100,000 over five years, has been established to advance critical initiatives within the Section of Movement Disorders at Washington University School of Medicine in St. Louis Department of Neurology. This significant financial contribution is earmarked for two primary functions under the direction of Joel Perlmutter, MD: funding […]
Remarkably, Doug Whitney, 75, has escaped genetic destiny. Like many members of his family, Whitney inherited a rare genetic mutation that all but guarantees he would develop early-onset Alzheimer’s disease. But Whitney, whose relatives first showed symptoms of cognitive decline in their early 50s, remains mentally sharp with no signs of the devastating disease, and […]